While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

Pre-eclampsia dey lead to 70,000 maternal deaths annually, but how e take start still be mystery. Dis article torchlight ...

The cost of SARMs can vary depending on the supplier, dosage, and cycle length. Typically, SARMs range from $80 to $200 per ...

Nurix Therapeutics Inc. (NRIX) presented positive clinical data from its ongoing Phase 1a/1b clinical trial of NX-5948, an orally ...